Target intelligence / Profile preview

Ovarian granulosa cell apoptosis

01

Overview

Ovarian granulosa cell apoptosis is the process by which granulosa cells within the ovarian follicle undergo programmed cell death, a key event governing follicular atresia (degeneration of non-dominant follicles), and ultimately, the regulation of female fertility and reproductive lifespan. Granulosa cell apoptosis is triggered by both intrinsic (mitochondrial) and extrinsic (death receptor-mediated) pathways, involving regulatory molecules such as Bcl-2 family proteins, caspases, the Fas/FasL system, and is affected by oxidative stress and hormonal signals. This process is a primary determinant of follicle pool size and is implicated in conditions including premature ovarian insufficiency and age-related reproductive decline. Although not itself a “target,” the molecular regulators of granulosa cell apoptosis (e.g., Bcl-2, Fas receptor, TGFBR2, miRNAs such as miR-187, lncRNA NORHA) may be therapeutic targets for interventions aiming to preserve follicle number or treat female infertility. Note: "Ovarian granulosa cell apoptosis" is a cellular process, not a discrete molecular target or receptor. For drug development or mechanistic studies, focus shifts to individual apoptosis-regulating molecules (such as Bcl-2, Fas receptor, TGF-β, MAPK, PI3K-Akt) or signaling pathways (e.g., TGF-β, MAPK, PI3K-Akt), not the phenomenon as a whole.

Other names
Granulosa cell apoptosisGC apoptosisOvarian follicular atresia
02

Biological functions

ApoptosisFollicular atresiaOvarian follicle maturationCell death
03

Disease associations

Female infertilityPremature ovarian insufficiencyReproductive aging
04

Biomarkers

Changes in Bcl-2 family proteins (Bax, Bcl-2, etc.)Caspase activationSteroid hormone levels (indirect)DNA fragmentation (TUNEL positivity)

Beyond the preview

Go deeper on Ovarian granulosa cell apoptosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovarian granulosa cell apoptosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call